Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEVA PHARMACEUTICAL INDUSTRIES, LTD.”

302 pharma patents match "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 302
Index total 30,257
Page 12 / 13

Quick answer

This filtered view shows 302 pharmaceutical patents matching "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

302 results for “TEVA PHARMACEUTICAL INDUSTRIES, LTD.” · 30,257 patents in full index Clear search

  1. US 6635765

    Processes for preparing torsemide intermediate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 21, 2003 · Expires Oct 16, 2023

    expired
  2. US 6630514

    Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 7, 2003 · Expires Oct 2, 2023

    expired
  3. US 6624292

    Processes for preparing clarithromycin polymorphs

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 23, 2003 · Expires Sep 18, 2023

    expired
  4. US 6610718

    Processes for making- and a new crystalline form of- leflunomide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 26, 2003 · Expires Aug 21, 2023

    expired
  5. US 6605636

    Atorvastatin hemi-calcium form VII

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 12, 2003 · Expires Aug 7, 2023

    expired
  6. US 6599884

    Processes for preparing clarithromycin polymorphs and novel polymorph IV

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 29, 2003 · Expires Jul 24, 2023

    expired
  7. US 6600073

    Methods for preparation of sertraline hydrochloride polymorphs

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 29, 2003 · Expires Jul 24, 2023

    expired
  8. US 6592869

    Vaccine composition and method of using the same

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 15, 2003 · Expires Jul 10, 2023

    expired
  9. US 6576764

    Synthesis and crystallization of piperazine ring-containing compounds

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 10, 2003 · Expires Jun 5, 2023

    expired
  10. US 6569459

    Method of administration of paclitaxel-plasma protein formulation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 27, 2003 · Expires May 22, 2023

    expired
  11. US 6558659

    Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 6, 2003 · Expires May 1, 2023

    expired
  12. US 6555585

    Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 29, 2003 · Expires Apr 24, 2023

    expired
  13. US 6545149

    Synthesis and crystallization of piperazine ring-containing compounds

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 8, 2003 · Expires Apr 3, 2023

    expired
  14. US 6541001

    Vaccine composition and method of using the same

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 1, 2003 · Expires Mar 27, 2023

    expired
  15. US 6538025

    Aminoindan derivatives

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 25, 2003 · Expires Mar 20, 2023

    expired
  16. US 6531509

    Stable gabapentin containing more than 20 ppm of chlorine ion

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 11, 2003 · Expires Mar 6, 2023

    expired
  17. US 6528685

    Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 4, 2003 · Expires Feb 27, 2023

    expired
  18. US 6528661

    Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 4, 2003 · Expires Feb 27, 2023

    expired
  19. US 6500987

    Sertraline hydrochloride polymorphs

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired
  20. US 6495721

    Sertraline hydrochloride Form II and methods for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 17, 2002 · Expires Dec 12, 2022

    expired
  21. US 6492426

    Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 10, 2002 · Expires Dec 5, 2022

    expired
  22. US 6482417

    Stable pharmaceutical formulation comprising torsemide modification II

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 19, 2002 · Expires Nov 14, 2022

    expired
  23. US 6476006

    Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 5, 2002 · Expires Oct 31, 2022

    expired
  24. US 6465496

    Torsemide polymorphs

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 15, 2002 · Expires Oct 10, 2022

    expired